Opportunity Information: Apply for RFA AI 20 020

The Tuberculosis Research Units (TBRUs) funding opportunity, titled "Tuberculosis Research Units (U19 Clinical Trial Optional)" (Funding Opportunity Number RFA-AI-20-020), is a National Institutes of Health (NIH) discretionary grant program that uses a cooperative agreement mechanism (U19). Its central aim is to establish multidisciplinary TB Research Units that function together as a coordinated, collaborative network. The overall scientific focus is on improving understanding of how Mycobacterium tuberculosis (Mtb) interacts with the human host, with particular emphasis on identifying and characterizing the bacterial and host factors that matter at different stages of infection and active disease, and on studying how variation (heterogeneity) in both the pathogen and the host influences disease trajectories and outcomes.

A key feature of the program is the expectation of team-based, integrated research. Rather than supporting isolated projects, the FOA is designed to build interconnected units that bring together multiple disciplines to tackle complex questions about Mtb-host interactions. The research scope highlighted in the announcement includes careful characterization of determinants on both sides of the interaction: bacterial determinants (for example, strain differences and pathogen biology that shape infection or persistence) and host determinants (such as immune responses and other host traits that influence susceptibility, progression, or treatment response). The FOA also stresses analyses of heterogeneity, meaning applicants are encouraged to address how differences among bacterial populations and differences among hosts can lead to different clinical and biological outcomes. Clinical trials are optional under this announcement, which signals that applicants may propose clinical trial components if scientifically justified, but they are not required to do so.

From an administrative standpoint, this is a health-related funding opportunity under CFDA 93.855. The award ceiling is listed as $1,800,000, indicating the upper limit the agency expects to provide per award according to the posted opportunity details. The opportunity was created on March 30, 2020, with an original closing date of September 28, 2020, and it anticipated making multiple awards (the posted field indicates expected awards, though the precise number is not specified in the provided data). As a cooperative agreement, the U19 mechanism typically implies substantial programmatic involvement by NIH staff compared with a standard research project grant, consistent with the networked, collaborative structure described for the TBRUs.

Eligibility is intentionally broad and includes a wide range of domestic applicants: state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses. The FOA also explicitly calls out additional eligible applicant categories, reflecting an emphasis on inclusivity and the ability to engage diverse institutions and communities in TB research. These include Alaska Native and Native Hawaiian Serving Institutions; Asian American, Native American, and Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); Indian/Native American Tribal Governments other than federally recognized entities; faith-based or community-based organizations; eligible federal agencies; regional organizations; U.S. territories or possessions; and non-domestic (non-U.S.) entities (foreign organizations). This breadth supports the idea that the program can incorporate expertise, patient populations, and research settings from many contexts, including international environments where TB burden may be high, while still operating under NIH oversight and the cooperative agreement framework.

In practical terms, applicants to this FOA would be proposing a unit that contributes to a larger network, with a research plan aligned to the program priorities: mechanistic understanding of Mtb-host biology across infection and disease, and rigorous investigation of how pathogen and host variability shapes outcomes. The "Research Units" framing suggests an emphasis on organized, multi-project structures that can sustain collaboration, share approaches and data, and collectively move the field forward rather than producing disconnected findings.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Tuberculosis Research Units (U19 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.855.
  • This funding opportunity was created on 2020-03-30.
  • Applicants must submit their applications by 2020-09-28. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $1,800,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA AI 20 020

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for Tuberculosis Research

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)

Previous opportunity: Limited Competition: NIDDK Program Projects (P01 Clinical Trial Optional)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AI 20 020

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AI 20 020) also looked into and applied for these:

Funding Opportunity
Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Optional) Apply for PAR 20 152

Funding Number: PAR 20 152
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required) Apply for PAR 20 154

Funding Number: PAR 20 154
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) Apply for PAR 20 153

Funding Number: PAR 20 153
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional) Apply for PAR 20 156

Funding Number: PAR 20 156
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) Apply for PAR 20 157

Funding Number: PAR 20 157
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed) Apply for PAR 20 158

Funding Number: PAR 20 158
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) Apply for PAR 20 159

Funding Number: PAR 20 159
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Furthering Health System Reforms in Ukraine Apply for RFI 121 20 000001

Funding Number: RFI 121 20 000001
Agency: Ukraine USAID-Kiev
Category: Health
Funding Amount: Case Dependent
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) Exploratory/Developmental Research Projects (UH2 Clinical Trial Optional) Apply for RFA AA 20 008

Funding Number: RFA AA 20 008
Agency: National Institutes of Health
Category: Health
Funding Amount: $175,000
NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional) Apply for RFA MH 20 525

Funding Number: RFA MH 20 525
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional) Apply for PA 20 070

Funding Number: PA 20 070
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (R01) Apply for RFA HS 20 003

Funding Number: RFA HS 20 003
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Clinical Trials in Organ Transplantation in Children and Adults (CTOT-CA) (U01 Clinical Trial Optional) Apply for RFA AI 20 029

Funding Number: RFA AI 20 029
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Implementation Research to Improve Case Finding, Cascade Screening, and Treatment for Familial Hypercholesterolemia (FH) (R61/R33 Clinical Trial Required) Apply for RFA HL 22 006

Funding Number: RFA HL 22 006
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) Apply for RFA RM 20 019

Funding Number: RFA RM 20 019
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Noninvasive mTBI Tool RFI Apply for HU000120R0047

Funding Number: HU000120R0047
Agency: Uniformed Services Univ. of the Health Sciences
Category: Health
Funding Amount: Case Dependent
IDeA Program Infrastructure for Clinical and Translational Research (IDeA-CTR)(U54 - Clinical Trial Optional) Apply for PAR 20 175

Funding Number: PAR 20 175
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed). Apply for RFA AI 20 027

Funding Number: RFA AI 20 027
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Competitive Revision Supplements to Existing AHRQ Patient Centered Outcomes Research (PCOR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional) Apply for PA 20 072

Funding Number: PA 20 072
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) Apply for PAR 20 178

Funding Number: PAR 20 178
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AI 20 020", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: